OVERVIEW

Cancer

Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
 
Andrew Perkins
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Nicholas Andrew Saunders
Show More ...
CANCER RESEARCH PROGRAMS
Click a program below to learn more
 
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
GALLERY
Interview with Prof John Hooper about pancreatic cancer research
Article
World-first skin cancer treatment aims to help transplant patients A new medication which can be applied to the skin could help prevent organ transplant recipients from developing harmful skin...Read more
Article
Drug research pivoted from prostate cancer to COVID-19 treatment Two drugs under development to treat aggressive prostate cancer will be tested to combat the deadliest response to COVID-19 infection...Read more
Article
Genome a treasure trove for new disease treatments and diagnostics Queensland scientist Dr Mark Adams is uncovering potential new treatment targets and diagnostics for a range of diseases, including...Read more
Article
Clinician-researcher focuses on patients with rare lymphoma Haematologist, Dr Colm Keane, has a clear focus on improving patient outcomes through his lymphoma research program at the Translational...Read more
Article
Awakening the immune system to fight diseases Scientists at The Translational Research Institute (TRI) are harnessing the body’s front-line immune cells to fight cancer, with potential new...Read more
Article
New autoimmune disease and cancer therapeutics edging closer to reality for patients A career dedicated to rheumatoid arthritis has led Professor Ranjeny Thomas AM to the development of a potential...Read more
Article
Fresh tumour biopsies in world-first technique for cancer treatments University of Queensland researchers have developed an innovative technique to help pharmaceutical and technology companies design...Read more
Article
Researchers optimising cancer survivors’ outcomes Brisbane cancer nurse scientists are working alongside clinicians and scientists to develop better healthcare models for cancer survivors. QUT...Read more
Article
Improving genetic testing for skin cancer Genetic researcher and counsellor, Dr Aideen McInerney-Leo is leading a series of multifaceted studies aimed at improving genetic testing for skin cancer ...Read more
Article
TRI-based Mater researchers in partnership with The University of Queensland have developed a new cancer vaccine, which has shown promising signs in preclinical laboratory studies. Funded by grants...Read more

Pages